Pharmacogenetics of antidepressants

Crisafulli, Concetta, Fabbri, Chiara, Porcelli, Stefano, Drago, Antonio, Spina, Edoardo, De Ronchi, Diana, Serretti, Alessandro·2011·Frontiers in Pharmacology

DOI 10.3389/fphar.2011.00006

Cites (418)

Items 201–400 of 431

Analysis of Association Between the Serotonin Transporter and Antidepressant Response in a Large Clinical Sample
James C. Ballenger · 2008 · Yearbook of Psychiatry and Applied Mental Health
Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder
Andrew F. Leuchter, James T. McCracken, Aimee M. Hunter, Ian A. Cook, Jonathan E. Alpert · 2009 · Journal of Clinical Psychopharmacology
Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response
Katharina Domschke, Bruce R. Lawford, Gonzalo Laje, Klaus Berger, Ross McD. Young, Charles Phillip Morris, Jürgen Deckert, Volker Arolt, Francis J. McMahon, Bernhard Theodor Baune · 2009 · The International Journal of Neuropsychopharmacology
Effect of antidepressants on striatal and accumbens extracellular dopamine levels
Junji Ichikawa, Herbert Y. Meltzer · 1995 · European Journal of Pharmacology
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression
Ari Illi, Eija Setälä-Soikkeli, Merja Viikki, Outi Poutanen, Heini Huhtala, Nina Mononen, Terho J. Lehtimäki, Esa V. J. Leinonen, Olli Kampman · 2009 · Neuroreport
Pharmacogenomics of antidepressant drugs.
S. Horstmann, E. Binder · 2009 · Pharmacology and Therapeutics
Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
Matthew John Taylor, Srijan Sen, Zubin Bhagwagar · 2010 · Biological Psychiatry
The Role of P-Glycoprotein and Canalicular Multispecific Organic Anion Transporter in the Hepatobiliary Excretion of Drugs
Hiroyuki Kusuhara, Hiroshi Suzuki, Yuichi Sugiyama · 1998 · Journal of Pharmaceutical Sciences
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy
Murray J.V. Wilkie, Gillian C. Smith, Richard K. Day, Keith Matthews, Daniel J. Smıth, Douglas Blackwood, Ian Reid, C. Roland Wolf · 2008 · The Pharmacogenomics Journal
Genetic variations in tryptophan hydroxylase in suicidal behavior
Dan Rujescu, Ina Giegling, Tetsuya Sato, Annette M. Hartmann, Hans‐Jürgen Möller · 2003 · Biological Psychiatry
Pharmacogenetic response to antidepressants in a multicase family with affective disorder
Richard L. O’Reilly, Lisa Bogue, Shiva M. Singh · 1994 · Biological Psychiatry
Chronic Duloxetine Treatment Induces Specific Changes in the Expression of BDNF Transcripts and in the Subcellular Localization of the Neurotrophin Protein
Francesca Calabrese, Raffaella Molteni, Paola Francesca Maj, Annamaria Cattaneo, Massimo Gennarelli, Giorgio Racagni, Marco Andrea Riva · 2007 · Neuropsychopharmacology
A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13.
M. Ansari-Lari, D. Muzny, Jing Lu, Fei Lu, C. Lilley, S. Spanos, T. Malley, Richard A. Gibbs · 1996 · Genome Research
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Cristina Lorenzi, Enrico Smeraldi · 2001 · European Neuropsychopharmacology
Genetic Polymorphisms of Cytochrome P450 Enzymes Influence Metabolism of the Antidepressant Escitalopram and Treatment Response
Ming‐Hsien Tsai, Keh-Ming Lin, Mei‐Chun Hsiao, Winston W. Shen, Mong‐Liang Lu, Hwa‐Sheng Tang, Chun-Kai Fang, Chi‐Shin Wu, Shao‐Chun Lu, Shu Chih Liu et al. · 2010 · Pharmacogenomics
Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project
Nader Ali Perroud, Rudolf Uher, Mandy Ng, Michel Guipponi, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole N Mors, Massimo Gennarelli, Marcella Rietschel et al. · 2010 · The Pharmacogenomics Journal
Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
Jantien P. Brouwer, Bente C. Appelhof, Elisabeth F. C. van Rossum, Jan Willem Koper, Eric Fliers, Jochanan Huyser, Aart H. Schene, Jan G.P. Tijssen, Richard van Dyck, Steven W. J. Lamberts et al. · 2006 · Psychoneuroendocrinology
Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram
Bárbara Arias, Rosa Catalán, Cristòbal Gastó, Blanca Gutiérrez, Lourdes Fañanás · 2005 · Journal of Psychopharmacology
Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression
David H. Overstreet, Guy Griebel · 2004 · European Journal of Pharmacology
Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes
Hymie Anisman, Larry Kokkinidis, Zul Merali · 2002 · Brain Behavior and Immunity
Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin
Bárbara Arias, Alessandro Serretti, Cristina Lorenzi, Cristòbal Gastó, Rosa Catalán, Lourdes Fañanás · 2005 · Journal of Affective Disorders
The Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Patricia A. Seymour, Anne W. Schmidt, David W. Schulz · 2003 · CNS Drug Reviews
Variability in the serotonin transporter gene and increased risk for major depression with melancholia
Blanca Gutiérrez, Luís Pintor, Cristòbal Gastó, Araceli Rosa, Jaume Bertranpetit, Eduard Vieta, Lourdes Fañanás · 1998 · Human Genetics
Association between a G-protein β3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders
H-J Lee, J-H Cha, B-J Ham, C-S Han, YK Kim, Soo Hoon Lee, S-H Ryu, Kang Rh, M-J Choi, M-S Lee · 2003 · The Pharmacogenomics Journal
Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project
Nader Ali Perroud, Katherine Jean Aitchison, Rudolf Uher, Rebecca G. Smith, Patricia Huezo-Diaz, Andrej Marušič†, Wolfgang Maier, Ole N Mors, Anna Placentino, Neven Henigsberg et al. · 2009 · Neuropsychopharmacology
Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein β3 subunit as predictors of response to fluoxetine and nortriptyline
Peter R. Joyce, Roger Mulder, Suzanne E. Luty, Janice M. McKenzie, Allison L. Miller, Geraldine R. Rogers, Martin Alexander Kennedy · 2003 · The International Journal of Neuropsychopharmacology
Effect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder
Masaki Kato, Tsuyoshi Fukuda, Masataka Wakeno, Gaku Okugawa, Yoshiteru Takekita, Syunsuke Watanabe, Megumi Yamashita, Yuka Hosoi, Junichi Azuma, Toshihiko Kinoshita et al. · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Serotonin Receptor 2A Gene Polymorphism (–1438A/G) and Short-Term Treatment Response to Citalopram
Myoung-Jin Choi, Rhee-Hun Kang, Byung‐Joo Ham, Han-Yong Jeong, Min-Soo Lee · 2005 · Neuropsychobiology
Identification of a Naturally Occurring Polymorphism in the Promoter Region of the Norepinephrine Transporter and Analysis in Major Depression
Peter Zill · 2002 · Neuropsychopharmacology
Polymorphisms in the CYP 2D6 Gene: Association with Plasma Concentrations of Fluoxetine and Paroxetine
Corinne Charlier, Franck Broly, Michel Lhermitte, Emmanuel Pinto, Marc Ansseau, Guy J. Plomteux · 2003 · Therapeutic Drug Monitoring
Human cytochrome P450s: selectivity and measurement in vivo
Dennis A. Smith, S. M. ABEL, Ruth Hyland, B. C. Jones · 1998 · Xenobiotica
Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder
Zou, Yan-Feng, Ye, Dong-Qing, Feng, Xiao-Liang, Su, Hong, Pan, Fa-Ming, Liao, Fang-Fang · 2010 · European Neuropsychopharmacology
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity
Cristina Cusin, Alessandro Serretti, Raffaella Zanardi, Enrico Lattuada, David Rossini, Roberta Lilli, Cristina Lorenzi, Enrico Smeraldi · 2002 · The International Journal of Neuropsychopharmacology
Association of the Serotonin Transporter Gene With Smoking Behavior
Kremer, Ilana, Bachner-Melman, Rachel, Reshef, Alon, Broude, Leonid, Nemanov, Lubov, Gritsenko, Inga, Heresco-Levy, Uriel, Elizur, Yoel, Ebstein, Richard P. · 2005 · American Journal of Psychiatry
Erratum to “Cytokines and major depression” [Prog. Neuropsychopharmacol. Biol. Psychiat. 29(2) (2005) 201–217]
Olga J.G. Schiepers, Marieke Wichers, Michael H. J. Maes · 2005 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients
Roy H. Perlis, Gonzalo Laje, Jordan W. Smoller, Maurizio Fava M. D, Augustus John Rush, Francis J. McMahon · 2009 · Neuropsychopharmacology
Lithium response and genetic variation in the CREB family of genes
Firoza Mamdani, Martin Alda, Paul Grof, Lionel Trevor Young, Guy Armand Rouleau, Gustavo Turecki · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Association of Norepinephrine Transporter Gene With Methylphenidate Response
Li Yang, Yufeng Wang, Jun Li, Stephen V. Faraone · 2004 · Journal of the American Academy of Child & Adolescent Psychiatry
Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers
Erik Gunnar Jönsson, Markus Maria Nöthen, Petter J Gustavsson, Helge Neidt, Roland Bunzel, Peter Propping, Göran C. Sedvall · 1998 · Psychiatry Research
MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression
Alma Mihaljević Peleš, Nada Božina, Marina Šagud, Martina Rojnić Kuzman, Mila Lovrić · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene
Thomas C. Baghai, Cornelius Schüle, Peter Zwanzger, Christo Minov, Peter Zill, Robin Ella, Daniela Eser, Sebnem Oezer, Brigitta Bondy, Rainer Rupprecht · 2002 · Neuroscience Letters
The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes
Howard Steiger, Ridha Joober, Mimi Israël, Simon N. Young, N.M.K. Ng Ying Kin, Lise I. Gauvin, Kenneth R. Bruce, Jasmine Joncas, Adam Torkamanzehi · 2004 · International Journal of Eating Disorders
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment
Julia Kirchheiner, Katharina Nickchen, J. Sasse, M Bauer, Ivar Roots, Jürgen Brockmöller · 2006 · The Pharmacogenomics Journal
Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics
Klaus‐Peter Lesch, Lise Gutknecht · 2004 · The International Journal of Neuropsychopharmacology
Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder
Keizo Yoshida, Shingo Naito, Hitoshi Takahashi, Kazuhiro Sato, Kenichi Ito, Mitsuhiro Kamata, Hisashi Higuchi, Tetsuo Shimizu, Kunihiko Itoh, Kazuyuki Inoue et al. · 2002 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Interaction between genetic polymorphisms and stressful life events in first episode depression
Jens Drachmann Bukh, Camilla Bock, Maj Vinberg, Thomas Mears Werge, Ulrik Gether, Lars Vedel Kessing · 2009 · Journal of Affective Disorders
The circadian system and the therapeutics of the affective disorders
David Healy, James M. Waterhouse · 1995 · Pharmacology & Therapeutics
Functional and Radioligand Binding Characterization of Rat 5-HT 6 Receptors Stably Expressed in HEK293 Cells
Frank Boess, Frederick J. Monsma, C. CAROLO, Valerie Meyer, Alain Rudler, Catherine Zwingelstein, Andrew J. Sleight · 1997 · Neuropharmacology
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Laje, Gonzalo, Perlis, Roy H., Rush, A. John, McMahon, Francis J. · 2009 · Psychiatric Services
Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients
Roy H. Perlis, Bonnie A. Fijal, Sweta Dharia, Alexandra N. Heinloth, Judy Houston · 2010 · Biological Psychiatry
ABCB1 (P-Glycoprotein/MDR1) Gene G2677T/A Sequence Variation (Polymorphism): Lack of Association with Side Effects and Therapeutic Response in Depressed Inpatients Treated with Amitriptyline
Barbara Laika, Stefan Leucht, Werner Steimer · 2006 · Clinical Chemistry
SSRIs antidepressant activity is influenced by Gβ3 variants
Alessandro Serretti · 2003 · European Neuropsychopharmacology
Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response
Shih‐Jen Tsai, Chen‐Jee Hong, Ying‐Jay Liou, Younger W.‐Y. Yu, Tai‐Jui Chen, Sheue-Jane Hou, Feng-Chang Yen · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine
K Ito, K. Yoshida, Kazuhiro Sato, Hitoshi Takahashi, Mitsuhiro Kamata, H Higuchi, Tetsuo Shimizu, Ken Itoh, Kazuyuki Inoue, Takehiko Tezuka et al. · 2002 · Psychiatry Research
Distinguishable Haplotype Blocks in the HTR3A and HTR3B Region in the Japanese Reveal Evidence of Association of HTR3B with Female Major Depression
Kazuo Yamada, Eiji Hattori, Yoshimi Iwayama, Tetsuo Ohnishi, Hisako Ohba, Tomoko Toyota, Hitomi Takao, Yoshio Minabe, Noriaki Nakatani, Teruhiko Higuchi et al. · 2006 · Biological Psychiatry
Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response
Eric J Peters, Susan L. Slager, G. Douglas Jenkins, Megan S. Reinalda, Holly A. Garriock, Stanley I. Shyn, Jeffrey B. Kraft, Patrick J. McGrath, Steven P. Hamilton · 2008 · Pharmacogenetics and Genomics
Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors
Miki Yamauchi, Takako Miyara, Tetsuya Matsushima, Taiichiro Imanishi · 2005 · Brain Research
Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project
Robert Keers, Rudolf Uher, Patricia Huezo-Diaz, Rebecca G. Smith, Sara R. Jaffee, Marcella Rietschel, Neven Henigsberg, Dejan Kozel, Ole N Mors, Wolfgang Maier et al. · 2010 · The Pharmacogenomics Journal
Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation
Maureen K. Hahn, Michelle S. Mazei‐Robison, Randy Blakely · 2005 · Molecular Pharmacology
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders
Mónica Gratacòs, Virginia Soria, Mikel Urretavizcaya, Juan R. González, José Manuel Crespo, Mónica Bayés, Rafael de Cid, José Manuel Menchón, J. Vallejo, Xavier Estivill · 2007 · The Pharmacogenomics Journal
The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men
Thomas C. Baghai, Cornelius Schüle, Peter Zill, Tobias Deiml, Daniela Eser, Peter Zwanzger, Robin Ella, Rainer Rupprecht, Brigitta Bondy · 2004 · Neuroscience Letters
HTR2A gene variation is involved in antidepressant treatment response
Susanne Lucae, Marcus Ising, Sonja Horstmann, Bernhard Theodor Baune, Volker Arolt, Bertram Müller-Myhsok, Florian Holsboer, Katharina Domschke · 2009 · European Neuropsychopharmacology
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism
Masaki Kato, Yuka Ikenaga, Masataka Wakeno, Gaku Okugawa, Kenji Nobuhara, Tsuyoshi Fukuda, Kazuhiro Fukuda, Junichi Azuma, Toshihiko Kinoshita · 2005 · International Clinical Psychopharmacology
The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders
John H. Kehne · 2007 · CNS & Neurological Disorders - Drug Targets
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine
Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, Hitoshi Takahashi, Kazuyuki Inoue, Toshio Suzuki, Kunihiko Itoh, Norio Ozaki · 2006 · Journal of Psychopharmacology
Association between Major Depressive Disorder and the –1438A/G Polymorphism of the Serotonin 2A Receptor Gene
Myoung-Jin Choi, Heon‐Jeong Lee, Hye-Jin Lee, Byung‐Joo Ham, Ji-Hyun Cha, Seung‐Ho Ryu, Min-Soo Lee · 2004 · Neuropsychobiology
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders
Alessandro Serretti, Cristina Cusin, David Rossini, Paola Artioli, Danilo Dotoli, Raffaella Zanardi · 2004 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Pharmacogenetics in the treatment of depression: pharmacodynamic studies
Alessandro Serretti, Paola Artioli, Roberto Quartesan · 2005 · Pharmacogenetics and Genomics
Association between -1438G/A Promoter Polymorphism in the 5-HT2A Receptor Gene and Fluvoxamine Response in Japanese Patients with Major Depressive Disorder
Kazuhiro Sato, Keizo Yoshida, Hitoshi Takahashi, Kenichi Ito, Mitsuhiro Kamata, Hisashi Higuchi, Tetsuo Shimizu, Kunihiko Itoh, Kazuyuki Inoue, Takehiko Tezuka et al. · 2002 · Neuropsychobiology
Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism
Angela Rousseva, Chantal Henry, Donatienne Van den Bulke, G Fournier, Jean Laplanche, Marion Leboyer, Frank Bellivier, JM Aubry, P Baud, Maria Boucherie et al. · 2003 · The Pharmacogenomics Journal
Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment
Mladen Vassilev Tzvetkov, Jürgen Brockmöller, Ivar Roots, Julia Kirchheiner · 2008 · Pharmacogenetics and Genomics
Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on theraputic outcome in affective disorders
Thomas C. Baghai, Cornelius Schüle, Peter Zwanzger, Christo Minov, Markus Schwarz, S. De Jonge, Rainer Rupprecht, Brigitta Bondy · 2001 · Molecular Psychiatry
Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder
Roy H. Perlis, Bonnie A. Fijal, David H. Adams, Virginia K. Sutton, Madhukar H. Trivedi, Judy Houston · 2008 · Biological Psychiatry
Increased Expression of 5-HT6 Receptors in the Rat Dorsomedial Striatum Impairs Instrumental Learning
Ellen Siobhan Mitchell, Timothy J. Sexton, John F. Neumaier · 2006 · Neuropsychopharmacology
Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response
Wenjiao Min, Tao Li, Xiaohong Ma, Zhengyu Li, Tao Yu, Dong Feng Gao, Bo Zhang, Yang Yun, Xueli Sun · 2009 · Psychopharmacology
Pharmacogenomics - it's not just pharmacogenetics
David Stanley Bailey, Alexander A. Bondar, L. Mike Furness · 1998 · Current Opinion in Biotechnology
The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting
Francesco Benedetti, Cristina Colombo, Adele Pirovano, Elena Marino, Enrico Smeraldi · 2008 · Psychopharmacology
A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression
Murray J.V. Wilkie, Daniel J. Smıth, Ian Reid, Richard K. Day, Keith Matthews, Charles Roland Wolf, Douglas Blackwood, Gillian C. Smith · 2007 · Pharmacogenetics and Genomics
Chronic Imipramine Is Associated with Diminished Hypothalamic-Pituitary-Adrenal Axis Responsivity in Healthy Humans
David Michelson, Elise Galliven, Lauren Hill, Mark A. Demitrack, George Panagiotis Chrousos, Philip W. Gold · 1997 · The Journal of Clinical Endocrinology & Metabolism
Polymorphisms in the 5-Hydroxytryptamine 2A Receptor and CytochromeP4502D6 Genes Synergistically Predict Fluvoxamine-Induced Side Effects in Japanese Depressed Patients
Yutaro Suzuki, Kazushi Sawamura, Toshiyuki Someya · 2005 · Neuropsychopharmacology
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients
Alessandro Serretti, Raffaella Calati, Isabelle Massat, Sylvie Linotte, Siegfried F. Kasper, Yves Lecrubier, R. S. Espel, Joseph Bollen, Joseph Zohar, Jacques A. Berlo et al. · 2009 · International Clinical Psychopharmacology
The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine
Takuro Sugai, Yutaro Suzuki, Kazushi Sawamura, Naoki Fukui, Yoshimasa Inoue, Toshiyuki Someya · 2006 · The Pharmacogenomics Journal
Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients
Shih‐Jen Tsai, Yung‐Tian A. Gau, Chen‐Jee Hong, Ying‐Jay Liou, Younger W.‐Y. Yu, Tai‐Jui Chen · 2008 · Journal of Affective Disorders
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies
Antonio Drago, Diana De Ronchi, Alessandro Serretti · 2007 · The International Journal of Neuropsychopharmacology
Hypothalamic–pituitary–adrenocortical system dysregulation and new treatment strategies in depression
Cornelius Schüle, Thomas C. Baghai, Daniela Eser, Rainer Rupprecht · 2009 · Expert Review of Neurotherapeutics
Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium
Bertrand Rochat, Pierre Baumann, Kenneth L. Audus · 1999 · Brain Research
Dissecting the phenotype in genome-wide association studies of psychiatric illness
Nick J. Craddock, Kenneth S. Kendler, Michael Churton Neale, John I. Nürnberger, Shaun Purcell, Marcella Rietschel, Roy H. Perlis, Susan L. Santangelo, Thomas G. Schulze, Thomas G. Schulze et al. · 2009 · The British Journal of Psychiatry
Norepinephrine and Serotonin Transporter Genes: Impact on Treatment Response in Depression
Anna Baffa, Christa Hohoff, Bernhard Theodor Baune, Carsten Müller‐Tidow, Nicola Tidow, Christine Margarete Freitag, Peter Zwanzger, Jürgen Deckert, Volker Arolt, Katharina Domschke · 2010 · Neuropsychobiology
Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment
Min-Soo Lee, Hwa‐Young Lee, Heon‐Jeong Lee, Seung‐Ho Ryu · 2004 · Psychiatric Genetics
Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder
Eugene Lin, Po See Chen, Hui Hua Chang, Po‐Wu Gean, Hsin Chun Tsai, Yen Kuang Yang, Ru‐Band Lu · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A
Sandra M. Villafuerte, Kamala Vallabhaneni, Elżbieta Śliwerska, Francis J. McMahon, Elizabeth A. Young, Margit Burmeister · 2009 · Psychiatric Genetics
Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala
Lawrence Patrick Reagan, Robert M. Hendry, Leah R. Reznikov, Gerardo G. Piroli, Gwendolyn E. Wood, Bruce S. McEwen, Claudia A. Grillo · 2007 · European Journal of Pharmacology
A Comparison of Lithium and T 3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report
Andrew Alan Nierenberg · 2006 · American Journal of Psychiatry
Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior
Santiago Ballaz, Huda Akil, Stanley J. Watson · 2007 · Neuroscience
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
Eduard Maron, Anu Tammiste, Kristi Kallassalu, Triin Eller, Veiko Vasar, David Nutt, Andres Metspalu · 2009 · European Neuropsychopharmacology
Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling
Jobst Landgrebe, Gerhard Welzl, Thomas Metz, Marcel M. van Gaalen, Hans‐Hilger Ropers, Wolfgang Wurst, F. Holsboer · 2002 · Journal of Psychiatric Research
Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression
Brigitta Bondy, Thomas C. Baghai, Peter Zill, Cornelius Schüle, Daniela Eser, Tobias Deiml, Peter Zwanzger, Robin Ella, Rainer Rupprecht · 2005 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers
Michael D. De Bellis, Thomas D. Geracioti, Margaret M. Altemus, Mitchel A. Kling · 1993 · Biological Psychiatry
Correspondence
Martin M Katz Ph.D, Charles L. Bowden, Peter Stokes MD, Regina C. Casper, Alan Frazer, Stephen H Koslow Ph.D, James Kocsis MD, Steven Secunda MD, Alan Swann MD, Nancy Berman Ph.D · 1997 · Neuropsychopharmacology
Influence of the genetic polymorphism in the 5′-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers
Sofia Pavanello, Alessandra Pulliero, Silvia Lupi, Pasquale Gregorio, Erminio Clonfero · 2005 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
5-HT2A receptor gene promoter polymorphism –1438A/G and bipolar disorder
Ik‐Seung Chee, Sung Won Lee, Jeong Lan Kim, S. K. Wang, Y. O. Shin, S. C. Shin, Y. H. Lee, H. M. Hwang, M. R. Lim · 2001 · Psychiatric Genetics
Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families.
Chun Xu, R. Schachar, R. Tannock, W. Roberts, M. Malone, J. Kennedy, C. Barr · 2001 · American journal of medical genetics
The MAOA T941G polymorphism and short‐term treatment response to mirtazapine and paroxetine in major depression
André Tadić, Matthias J. Müller, Dan Rujescu, Ralf Kohnen, Hans H. Stassen, Norbert Dahmen, Armin Szegedi · 2006 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample
William L. Coventry, Michael R. James, Lindon J. Eaves, Scott D. Gordon, Nathan A. Gillespie, Leanne Ryan, Andrew C. Heath, Grant W. Montgomery, Nicholas G. Martin, Naomi R. Wray · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea
Misuzu Tanaka, Daisuke Kobayashi, Yuko Murakami, Norio Ozaki, Tatsuyo Suzuki, Nakao Iwata, Koichi Haraguchi, Ichiro Ieiri, Naoko Kinukawa, Masako Hosoi et al. · 2007 · The International Journal of Neuropsychopharmacology
Serotonin transporter gene polymorphism influences age at onset in patients with bipolar affective disorder
Frank Bellivier, Maÿliss Leroux, Chantal Henry, Fadila Benhamed, F. Rouillon, Jean Laplanche, Marion Leboyer · 2002 · Neuroscience Letters
cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs
Noam Driguès, Tatyana Poltyrev, Corina Bejar, Marta Weinstock, Moussa B. H. Youdim · 2003 · Journal of Neural Transmission
STin2 Variant and Family History of Suicide as Significant Predictors of Suicide Completion in Major Depression
Catalina Lopez de Lara, Alexandre Dumais, Guy Armand Rouleau, ALAIN D. LESAGE, Mimi Dumont, Nadia Chawky, Martin Alda, Chawki Benkelfat, Gustavo Turecki · 2005 · Biological Psychiatry
Genome-wide association studies: past, present and future
Mark I. McCarthy, Joel N. Hirschhorn · 2008 · Human Molecular Genetics
CRH₁ receptor antagonists for the treatment of depression and anxiety.
Marcus Ising, Florian Holsboer · 2007 · Experimental and Clinical Psychopharmacology
Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence
Andreas Heinz, David A Goldman, J�rgen Gallinat, Günter Schumann, Imke Puls · 2004 · Psychopharmacology
Phenotype-genotype Relationship and Clinical Effects of Citalopram in Chinese Patients
Ophelia QP Yin, Yun Kwok Wing, Yuet Wah Cheung, Zhijun Kevin Wang, Siu-Ling Lam, Helen FK Chiu, Moses SS Chow · 2006 · Journal of Clinical Psychopharmacology
Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance
Holly A. Garriock, John J. B. Allen, P Delgado, Z Nahaz, Mitchel A. Kling, Linda L. Carpenter, Molly K. Burke, W. J. Burke, T Schwartz, Lauren B. Marangell et al. · 2005 · Molecular Psychiatry
Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression
Diana Owen, Lisheng Du, David Bakish, Y.D. Lapierre, Pavel D. Hrdina · 1999 · Psychiatry Research
Association between the 5‐HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder
Seung‐Hwan Lee, Kang-Joon Lee, Heon‐Jeong Lee, Byung‐Joo Ham, Seungho Ryu, MIN‐SOO LEE · 2005 · Psychiatry and Clinical Neurosciences
Association Study of the 5-HT6 Receptor Polymorphism (C267T) and Symptomatology and Antidepressant Response in Major Depressive Disorders
Wei-Hsin Wu, Sheue-Jane Huo, Chih-Ya Cheng, Chen‐Jee Hong, Shih‐Jen Tsai · 2001 · Neuropsychobiology
Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder
E. Masoliver, A Menoyo, Víctor Pérez, Vı́ctor Volpini, Elisabet del Rio, Josefina Pérez‐Blanco, Enric Álvarez, Monserrat Baiget · 2006 · Psychiatric Genetics
HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort
Taro Kishi, Reiji Yoshimura, Tsuyoshi Kitajima, Tomo Okochi, Takenori Okumura, Tomoko Tsunoka, Yoshio Yamanouchi, Yoko Kinoshita, Kunihiro Kawashima, Hiroshi Naitoh et al. · 2009 · NeuroMolecular Medicine
Influence of the tyrosine hydroxylase val81met polymorphism and catechol‐O‐methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
Keizo Yoshida, Hisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, Kazuhiro Sato, Kazuyuki Inoue, Toshio Suzuki, Kunihiko Itoh, Norio Ozaki · 2007 · Human Psychopharmacology Clinical and Experimental
Association of Brain-Derived Neurotrophic Factor Genetic Val66Met Polymorphism with Severity of Depression, Efficacy of Fluoxetine and Its Side Effects in Chinese Major Depressive Patients
Yanfeng Zou, Yu Wang, Ping Liu, Xiao-Liang Feng, Binyan Wang, Tonghua Zang, Xin Yu, Jing Wei, Zhongchun Liu, Ying Liu et al. · 2009 · Neuropsychobiology
Role of 5-HT6 receptors in memory formation
A. Meneses · 2001 · Drug News & Perspectives
Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor
Cathy L. Barr, K. Wigg, Yu Feng, Gwyneth C. Zai, MOLLY A. MALONE, Wendy Roberts, Russell James Schachar, Rosemary Tannock, James L. Kennedy · 2000 · Molecular Psychiatry
The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression
Fridolin Sulser · 2002 · Annals of Medicine
No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment
Hitoshi Takahashi · 2002 · European Neuropsychopharmacology
Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression
Kang Rh, Chang Hs, Ma‐Li Wong, Myeongjin Choi, Ji Young Park, HY Lee, IK Jung, S-H Joe, L. Kim, Seung‐Hyun Kim et al. · 2009 · Journal of Psychopharmacology
Investigation of the human serotonin receptor geneHTR3Bin bipolar affective and schizophrenic patients
Bernd Frank, Beate Niesler, Markus Maria Nöthen · 2004 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Unique patterns of FOS, phospho-CREB and BrdU immunoreactivity in the female rat brain following chronic stress and citalopram treatment
S. D. Kuipers, Andrea Trentani, Christel Westenbroek, Clive R. Bramham, Jakob Korf, Ido P. Kema, Gert J. Ter Horst, Johan A. den Boer · 2005 · Neuropharmacology
The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients
Yutaro Suzuki, Kazushi Sawamura, Toshiyuki Someya · 2004 · The Pharmacogenomics Journal
Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population
Byung‐Joo Ham, Boung‐Chul Lee, Jong‐Woo Paik, Rhee-Hun Kang, Myoung-Jin Choi, Ihn‐Geun Choi, Min-Soo Lee · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study
Neslihan Aygün Kocabaş, Carole Faghel, Mara Barreto, Siegfried F. Kasper, Sylvie Linotte, Julien Mendlewicz, Magali Noro, Pierre Oswald, Daniel Souery, Joseph Zohar et al. · 2010 · International Clinical Psychopharmacology
No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors
Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Roberta Lilli, Cristina Lorenzi, Enrico Lattuada, Enrico Smeraldi · 2001 · Psychiatry Research
Mode of inheritance in mood disorder families according to fluvoxamine response
Alessandro Serretti, L. Franchini, M. Gasperini, Raffaella Rampoldi, Enrico Smeraldi · 1998 · Acta Psychiatrica Scandinavica
Serotonin receptor 1A −1019C/G variant: Impact on antidepressant pharmacoresponse in melancholic depression?
Bernhard Theodor Baune, Christa Hohoff, Tilmann Roehrs, J. Deckert, Volker Arolt, Katharina Domschke · 2008 · Neuroscience Letters
Functional Genomic Technologies: Creating New Paradigms for Fundamental and Applied Biology
C.M. Kao · 1999 · Biotechnology Progress
Beta‐1‐adrenergic receptor gene in major depression: Influence on antidepressant treatment response
Peter Zill, Thomas C. Baghai, Rolf R. Engel, Peter Zwanzger, Cornelius Schüle, Christo Minov, Stefanie Behrens, Ronald Bottlender A, Markus Jäger, Rainer Rupprecht et al. · 2003 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not?
Verbaten, Marinus N. · 2009 · Human Psychopharmacology: Clinical and Experimental
Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1
Anna Secher, Jens Drachmann Bukh, Camilla Bock, Pernille Koefoed, Henrik Berg Rasmussen, Thomas Mears Werge, Lars Vedel Kessing, Erling T. Mellerup · 2009 · International Clinical Psychopharmacology
Pharmacogenetics of antidepressant response: An update
Antonio Drago, Diana De Ronchi, Alessandro Serretti · 2008 · Human Genomics
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression
Alessandro Serretti, Alberto Chiesa, Raffaella Calati, Isabelle Massat, Sylvie Linotte, Siegfried F. Kasper, Yves Lecrubier, Irina A. Antonijevic, Carlos Forray, Lenore Snyder · 2010 · Journal of Affective Disorders
Assessment of Human Serotonin 1A Receptor Polymorphisms and SSRI Responsiveness
Gary M. Levin, Toya M. Bowles, Megan J. Ehret, Taimour Yousef Langaee, Jennifer Y. Tan, Julie A. Johnson, William J. Millard · 2007 · Molecular Diagnosis & Therapy
Serotonin Transporter Polymorphism and Harm Avoidance Personality in Chronic Tension‐Type Headache
Jeong Wook Park, Joong‐Seok Kim, Hae Kook Lee, Yeong In Kim, Kwang Soo Lee · 2004 · Headache The Journal of Head and Face Pain
Serotonin transporter regulatory region polymorphism is associated with anorexia nervosa
Sachio Matsushita, Kenji S. SUZUKI, Masanobu Murayama, Naoki Nishiguchi, Akitoyo Hishimoto, Aya Takeda, Osamu Shirakawa, Susumu Higuchi · 2004 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Interaction between SERTPR and stressful life events on response to antidepressant treatment
Laura Mandelli, Elena Marino, Adele Pirovano, Raffaella Calati, Raffaella Zanardi, Cristina Colombo, Alessandro Serretti · 2008 · European Neuropsychopharmacology
Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants
Enrico Smeraldi, Alessandro Serretti, Paola Artioli, Cristina Lorenzi, Marco Catalano · 2006 · Psychiatric Genetics
A case-control and family-based association study of the 5-HTTLPR in pediatric-onset depressive disorders
Maria Nobile, Maria Giulia Cataldo, Roberto Giorda, Marco Battaglia, Cinzia Baschirotto, Monica Bellina, Cecilia Marino, Massimo Molteni · 2004 · Biological Psychiatry
Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder
Alessandro Serretti, Paola Artioli, Raffaella Zanardi, Cristina Lorenzi, David Rossini, Cristina Cusin, Alessia Arnoldi, Marco Catalano · 2004 · Psychopharmacology
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients
Paul W. Schenk, Martin van Vliet, Ron A. A. Mathôt, Teun van Gelder, Arnold G. Vulto, Marianne van Fessem, S Verploegh-Van Rij, Jan Willem Lindemans, J A Bruijn, Ron H. N. van Schaik · 2009 · The Pharmacogenomics Journal
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
Magali Noro, Irina A. Antonijevic, Carlos Forray, Siegfried F. Kasper, Neslihan Aygün Kocabaş, Yves Lecrubier, Sylvie Linotte, Julien Mendlewicz, Stuart Montgomery, Lenore Snyder et al. · 2010 · International Clinical Psychopharmacology
Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders
Cristina Cusin, Alessandro Serretti, Enrico Lattuada, Roberta Lilli, Cristina Lorenzi, Laura Mandelli, Elisa Pisati, Enrico Smeraldi · 2001 · Journal of Psychiatric Research
Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo
Susan K. Hemrick-Luecke, Harold D. Snoddy, Ray W. Fuller · 1994 · Life Sciences
Serotonin transporter gene polymorphisms and treatment-resistant depression
Cristian Bonvicini, Alessandra Minelli, Catia Scassellati, Marco Bortolomasi, Matilde Segala, Riccardo Sartori, Mario Giacopuzzi, Massimo Gennarelli · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs
Johanna Hilli, Tuija Heikkinen, Riikka Rontu, Terho J. Lehtimäki, Ikuko Kishida, Eleni Aklillu, Leif Bertilsson, Tero J. Vahlberg, Kari Laine · 2009 · European Neuropsychopharmacology
Variation in GNB3 predicts response and adverse reactions to antidepressants
Robert Keers, Cristian Bonvicini, Catia Scassellati, Rudolf Uher, Anna Placentino, Caterina Giovannini, Marcella Rietschel, Neven Henigsberg, Dejan Kozel, Ole N Mors et al. · 2010 · Journal of Psychopharmacology
Antidepressant activity and calcium signaling cascades
Ian A. Paul · 2001 · Human Psychopharmacology Clinical and Experimental
Dose-Dependent Effects of the 3435 C>T Genotype of ABCB1 Gene on the Steady-State Plasma Concentration of Fluvoxamine in Psychiatric Patients
Naoki Fukui, Yutaro Suzuki, Kazushi Sawamura · 2007 · Therapeutic Drug Monitoring
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach
Sami A. K. Anttila, Olli Kampman, Ari Illi, Riikka Rontu, Terho J. Lehtimäki, Esa V. J. Leinonen · 2007 · BMC Psychiatry
Clinical and Genetic Dissection of Anger Expression and CREB1 Polymorphisms in Major Depressive Disorder
Roy H. Perlis, Shaun Purcell, Jesen A. Fagerness, Cristina Cusin, Lesley H. Yamaki, Maurizio Fava M. D, Jordan W. Smoller · 2007 · Biological Psychiatry
Serotonin Transporter Gene Polymorphisms and Sertraline Response in Major Depression Patients
Özlem Doğan, Nevzat Yüksel, Mehmet Ali Ergün, Akın Yılmaz, Mustafa Necmi ILHAN, Hatice Ersin Karslioglu, Ayşegül Koç, Adnan Menevşe · 2008 · Genetic Testing
Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder
Nada Božina, Alma Mihaljević Peleš, Marina Šagud, Hrvoje Bilusic, Miro Jakovljević · 2008 · The World Journal of Biological Psychiatry
Moclobemide Response in Depressed Patients: Association Study with a Functional Polymorphism in the Monoamine Oxidase A Promoter
D Müller, Thomas G. Schulze, Fabio M. Macciardi, Stephanie Ohlraun, M. M. Gross, Harald Scherk, Helge Neidt, Yana V. Syagailo, Markus Grässle, Markus Maria Nöthen et al. · 2002 · Pharmacopsychiatry
No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population
Byung‐Joo Ham, Min-Soo Lee, Heon‐Jeong Lee, Rhee-Hun Kang, Chang-Su Han, Myoung-Jin Choi, Seung Hwan Lee, Seungho Ryu · 2005 · Psychiatric Genetics
Predictors of response in depression
Karin F. Esposito, Paul J. Goodnick · 2003 · Psychiatric Clinics of North America
Potential Role of P-Glycoprotein in Affecting Hepatic Metabolism of Drugs
Win Loung Chiou, Sang M. Chung, Ta C. Wu · 2000 · Pharmaceutical Research
MAOA gene polymorphisms and response to mirtazapine in major depression
Dong‐Sheng Tzeng, Chia-Chang Chien, For‐Wey Lung, Chun‐ Yuh Yang · 2009 · Human Psychopharmacology Clinical and Experimental
Altered effect of dopamine transporter 3'UTR VNTR genotype on prefrontal and striatal function in schizophrenia.
D. Prata, A. Mechelli, M. Picchioni, Cynthia H. Y. Fu, T. Toulopoulou, E. Bramon, M. Walshe, R. Murray, D. Collier, P. McGuire · 2009 · Archives of General Psychiatry
TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response
Merja Viikki, Olli Kampman, Ari Illi, Eija Setälä-Soikkeli, Sami A. K. Anttila, Martti Huuhka, Timo Nuolivirta, Outi Poutanen, Nina Mononen, Terho J. Lehtimäki et al. · 2009 · Neuroscience Letters
Association analysis of Group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population
Tomoko Tsunoka, Taro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, Yoshio Yamanouchi, Yoko Kinoshita, Kunihiro Kawashima, Tomo Okochi, Takenori Okumura, Toshiya Inada et al. · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome
Murata, Yusuke, Kobayashi, Daisuke, Imuta, Nanae, Haraguchi, Koichi, Ieiri, Ichiro, Nishimura, Ryoji, Koyama, Susumu, Mine, Kazunori · 2010 · Journal of Clinical Psychopharmacology
Number of risk genotypes is a risk factor for major depressive disorder: a case control study
Holly A. Garriock, Pedro Delgado, Mitchel A. Kling, Linda L. Carpenter, Michael James Burke, W. J. Burke, Thomas L. Schwartz, Lauren B. Marangell, Mustafa M. Husain, Robert P. Erickson et al. · 2006 · Behavioral and Brain Functions
Pharmacogenetics of lithium response in bipolar disorder.
Martin Alda · 1999 · PubMed
No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment
Jens Drachmann Bukh, Camilla Bock, Maj Vinberg, Thomas Mears Werge, Ulrik Gether, Lars Vedel Kessing · 2009 · European Neuropsychopharmacology
A Polymorphism of the Norepinephrine Transporter Gene in Bipolar Disorder and Schizophrenia: Lack of Association
Anna Leszczyńska-Rodziewicz, Piotr M. Czerski, Paweł Kapelski, Sebastian Godlewski, Monika Dmitrzak‐Węglarz, JANUSZ K. RYBAKOWSKI, Joanna Hauser · 2002 · Neuropsychobiology
Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
André Tadić · 2008 · Neuropsychiatric Disease and Treatment
Antidepressant-elicited changes in gene expression
Mitsuhiko Yamada, Misa Yamada, Teruhiko Higuchi · 2005 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Relationship between G-Protein Beta-3 Subunit C825T Polymorphism and Mirtazapine Responses in Korean Patients with Major Depression
Rhee-Hun Kang, Sang‐Woo Hahn, Myoung-Jin Choi, Min‐Soo Lee · 2007 · Neuropsychobiology
The Serotonin Transporter Gene: Polymorphism and Haplotype Analysis in Russian Suicide Attempters
Darya Gaysina, Aigul Zainullina, Rail Gabdulhakov, Э. К. Хуснутдинова · 2006 · Neuropsychobiology
Genetic analysis with hierarchical models
John S. Witte · 1997 · Genetic Epidemiology
Examining SLV-323, a novel NK1 receptor antagonist, in a chronic psychosocial stress model for depression
Czéh, Boldizsár, Pudovkina, Olga, van der Hart, Marieke G. C., Simon, Mária, Heilbronner, Urs, Michaelis, Thomas, Watanabe, Takashi, Frahm, Jens, Fuchs, Eberhard · 2005 · Psychopharmacology
Association study of two polymorphisms of the serotonin‐2A receptor gene and suicide attempts
Concepción Vaquero‐Lorenzo, Enrique Baca‐García, Montserrat Díaz-Hernández, M. Mercedes Pérez-Rodríguez, Pablo Fernández‐Navarro, Lucas Giner, Juan Jose Carballo, Jeronimo Saiz‐Ruiz, José Fernández‐Piqueras, Enrique Baca Baldomero et al. · 2007 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Effects of anxiogenic drugs in rat forced swimming test
Tatjana Skrebuhhova, Lembit Allikmets, Vallo Matto · 1999 · Methods and Findings in Experimental and Clinical Pharmacology
Paroxetine Steady-State Plasma Concentration in Relation to CYP2D6 Genotype in Extensive Metabolizers
Vural Özdemir, Rachel Fynvola Tyndale, Ken L. Reed, Nathan Herrmann, Edward M. Sellers, WERNER KALOW, Claudio A. Naranjo · 1999 · Journal of Clinical Psychopharmacology
Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils
Conrad Gentsch, Margaret G. Cutler, Annick Vassout, Siem J. Veenstra, Felix Brugger · 2002 · Behavioural Brain Research
No Association of TPH1 218A/C Polymorphism with Treatment Response and Intolerance to SSRIs in Japanese Patients with Major Depression
Masaki Kato, Masataka Wakeno, Gaku Okugawa, Tsuyoshi Fukuda, Junichi Azuma, Toshihiko Kinoshita, Alessandro Serretti · 2007 · Neuropsychobiology
Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
Ari Illi, Outi Poutanen, Eija Setälä-Soikkeli, Olli Kampman, Merja Viikki, Heini Huhtala, Nina Mononen, Susann Haraldsson, Pasi A. Koivisto, Esa V. J. Leinonen et al. · 2010 · European Archives of Psychiatry and Clinical Neuroscience
The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study
Helen Lavretsky, Prabha Siddarth, Anand Kumar, Charles F. Reynolds · 2007 · International Journal of Geriatric Psychiatry
The Effect of Citalopram on Gene Expression Profile of Alzheimer Lymphocytes
András Palotás, László G. Puskás, Klára Kitajka, Miklós Palotás, József Molnár, Magdolna Pákáski, Zoltán Janka, Botond Penke, Janos L. Kalman · 2004 · Neurochemical Research
Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients
Masaki Kato, Masataka Wakeno, Gaku Okugawa · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Repeated co-treatment with imipramine and amantadine induces hippocampal brain-derived neurotrophic factor gene expression in rats.
Zofia Rogóż, Grażyna Skuza, Beata Legutko · 2007 · PubMed
Genetic polymorphisms in the treatment of depression: Speculations from an augmentation study using atomoxetine
Frederick W. Reimherr, Jay D. Amsterdam, David L. Dünner, Lenard A. Adler, Shuyu Zhang, David Wynne Williams, Barrie K. Marchant, David Michelson, Andrew Alan Nierenberg, Alan F. Schatzberg et al. · 2009 · Psychiatry Research
The role of substance P in depression: therapeutic implications
Markus Schwarz, Manfred Ackenheil · 2002 · Dialogues in Clinical Neuroscience
Association study ofCREB1 and childhood-onset mood disorders
Irina Burcescu, K. Wigg, Nicole A. King, Ágnes Vetró, Enikö Kiss, Livia Katay, James L. Kennedy, Mária Kovács, Cathy L. Barr · 2005 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: Reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice
Ulrike Böer, Christine Noll, Irmgard Cierny, Doris Krause, Christoph Hiemke, Willhart Knepel · 2010 · European Journal of Pharmacology
Pharmacogenetic Studies of Antidepressant Response: How Far from the Clinic?
Roy H. Perlis · 2007 · Psychiatric Clinics of North America
Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression
Francesco Benedetti, Alessandro Serretti, Cristina Colombo, Roberta Lilli, Cristina Lorenzi, Enrico Smeraldi · 2003 · Psychiatry Research
Influence of a functional polymorphism within the angiotensin I-converting enzyme gene on partial sleep deprivation in patients with major depression
Thomas C. Baghai · 2003 · Neuroscience Letters
Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation
Alessandro Serretti, Francesco Benedetti, Cristina Colombo, Roberta Lilli, Cristina Lorenzi, Enrico Smeraldi · 1999 · Psychiatry Research
Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by beta-1 adrenergic receptors
Alicia M. Crissman, Malath M. Makhay, James M. O’Donnell · 2001 · Psychopharmacology
Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence
Jerzy Samochowiec, Jolanta Kucharska–Mazur, Ryszard Kaminski, Michael N. Smolka, Hans Rommelschpacher, Catrin Wernicke, Agnieszka Tymicz, Lutz Schmidt · 2002 · Psychiatry Research
CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects
Koichi Ohara, Shigeru Tanabu, Kazuhisa Ishibashi, Keiko Ikemoto, Kimiko Yoshida, Haruo Shibuya · 2003 · European Journal of Clinical Pharmacology
CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype–phenotype association study design in translational pharmacogenetics
Yutaro Suzuki, Takuro Sugai, Naoki Fukui, Junzo Watanabe, Shin Ono, Yoshimasa Inoue, Vural Özdemir, Toshiyuki Someya · 2010 · Journal of Psychopharmacology